findmyKOL

Janice Gilden, MD

Basic profile

Rosalind Franklin University of Medicine and Science

ORCIDNone on fileNPI↗
RegionChicago, IL · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH funding1989–1991Why? →

Janice Gilden is an Endocrinology/Metabolic physician affiliated with Rosalind Franklin University of Medicine and Science. OpenAlex indexes 117 publications with 1,220 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
117publications

Distinct works indexed by OpenAlex.

1,220citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 1989–1991

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2222 W Division St Ste 320
Chicago, IL 606223096

Telephone

312-770-3263

Provider last certified this registry record 16 Mar 2021.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    72.8%
    Insulin Analog22.8%
    Basaglar Kwikpen U-10031%Humalog Kwikpen U-10028%Lantus Solostar25%Fiasp Flextouch16%
    Part D<11 patients
    Biguanide (metformin)22.3%
    Metformin Hcl58%Metformin Hcl Er42%
    Part D≥14 patients

    + 3 more classes in this area

  • Hormonal (systemic)

    18.8%
    l-Thyroxine11%
    Levothyroxine Sodium100%
    Part D≥17 patients
    Mineralocorticoids3.9%
    Fludrocortisone Acetate100%
    Part D<11 patients

    + 1 more class in this area

  • Cardiovascular

    4.7%
    alpha-Adrenergic Agonist4.7%
    Midodrine Hcl100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 1989–1991 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

45 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”